Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Novartis is giving away about 100 doses a year of the most expensive drug in the world, Zolgensma — a gene therapy that cures children of a deadly disease, the Wall Street Journal reports.
Between the lines: The free drug will be offered via a lottery system, which some patient groups say is inappropriate and unfair, as it fails to account for need.
- The program is designed to make the drug accessible to a limited number of patients outside of the U.S. There's a high demand for the $2.1 million drug in countries where it hasn't yet been approved.
My thought bubble: This is great news for a lucky few patients, but it's not a long-term solution to the world's issues with access to pricey drugs.
Go deeper: